Cargando…
Investigating zero transmission of HIV in the MSM population: a UK modelling case study
BACKGROUND: UNAIDS 90-90-90 goals for HIV have been surpassed in the UK, with focus now moving to ending transmission by 2030. The concept of zero transmission is complex and many factors can influence transmission. We aimed to investigate how the target of zero transmission might be reached in the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659044/ https://www.ncbi.nlm.nih.gov/pubmed/37986184 http://dx.doi.org/10.1186/s13690-023-01178-0 |
_version_ | 1785148275065618432 |
---|---|
author | Massey, Katherine Vardanega, Vittoria Chaponda, Mas Eddowes, Lucy A. Hearmon, Natalie |
author_facet | Massey, Katherine Vardanega, Vittoria Chaponda, Mas Eddowes, Lucy A. Hearmon, Natalie |
author_sort | Massey, Katherine |
collection | PubMed |
description | BACKGROUND: UNAIDS 90-90-90 goals for HIV have been surpassed in the UK, with focus now moving to ending transmission by 2030. The concept of zero transmission is complex and many factors can influence transmission. We aimed to investigate how the target of zero transmission might be reached in the UK. METHODS: We developed a de novo Markov state transition open cohort model of HIV with a 50-year time horizon, which models six key screening, treatment and prevention parameters, including treatment-as-prevention (TasP) and pre-exposure prophylaxis (PrEP). We studied the anticipated HIV epidemic trajectory over time in men who have sex with men (MSM), with and without changing the six key parameters, defining zero transmission as a 60% reduction in incidence compared with 2010 incidence. RESULTS: Zero transmission in the MSM population was not achieved within the model’s time horizon in our base case scenario, when the six key parameters were set to their 2019 values. Several future scenarios were explored, including a combination approach to preventing HIV transmission through increasing five key parameter values and considering three different TasP values; zero transmission was achieved by 2030 in the scenario where TasP was increased from its current level of 97–99%, avoiding 48,969 new HIV cases over the time horizon and reducing the lifetime risk of acquiring HIV for HIV-negative MSM not using PrEP from 13.65 to 7.53%. CONCLUSIONS: Zero transmission in the UK MSM population can be reached by the target year of 2030 with bold changes to HIV policy. A combination approach such as the UK Government’s ‘Towards Zero’ Action plan, impacting multiple policies and including an increase in TasP, has the potential to achieve meaningful reductions in HIV transmission and meet this ambitious goal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-023-01178-0. |
format | Online Article Text |
id | pubmed-10659044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106590442023-11-20 Investigating zero transmission of HIV in the MSM population: a UK modelling case study Massey, Katherine Vardanega, Vittoria Chaponda, Mas Eddowes, Lucy A. Hearmon, Natalie Arch Public Health Research BACKGROUND: UNAIDS 90-90-90 goals for HIV have been surpassed in the UK, with focus now moving to ending transmission by 2030. The concept of zero transmission is complex and many factors can influence transmission. We aimed to investigate how the target of zero transmission might be reached in the UK. METHODS: We developed a de novo Markov state transition open cohort model of HIV with a 50-year time horizon, which models six key screening, treatment and prevention parameters, including treatment-as-prevention (TasP) and pre-exposure prophylaxis (PrEP). We studied the anticipated HIV epidemic trajectory over time in men who have sex with men (MSM), with and without changing the six key parameters, defining zero transmission as a 60% reduction in incidence compared with 2010 incidence. RESULTS: Zero transmission in the MSM population was not achieved within the model’s time horizon in our base case scenario, when the six key parameters were set to their 2019 values. Several future scenarios were explored, including a combination approach to preventing HIV transmission through increasing five key parameter values and considering three different TasP values; zero transmission was achieved by 2030 in the scenario where TasP was increased from its current level of 97–99%, avoiding 48,969 new HIV cases over the time horizon and reducing the lifetime risk of acquiring HIV for HIV-negative MSM not using PrEP from 13.65 to 7.53%. CONCLUSIONS: Zero transmission in the UK MSM population can be reached by the target year of 2030 with bold changes to HIV policy. A combination approach such as the UK Government’s ‘Towards Zero’ Action plan, impacting multiple policies and including an increase in TasP, has the potential to achieve meaningful reductions in HIV transmission and meet this ambitious goal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-023-01178-0. BioMed Central 2023-11-20 /pmc/articles/PMC10659044/ /pubmed/37986184 http://dx.doi.org/10.1186/s13690-023-01178-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Massey, Katherine Vardanega, Vittoria Chaponda, Mas Eddowes, Lucy A. Hearmon, Natalie Investigating zero transmission of HIV in the MSM population: a UK modelling case study |
title | Investigating zero transmission of HIV in the MSM population: a UK modelling case study |
title_full | Investigating zero transmission of HIV in the MSM population: a UK modelling case study |
title_fullStr | Investigating zero transmission of HIV in the MSM population: a UK modelling case study |
title_full_unstemmed | Investigating zero transmission of HIV in the MSM population: a UK modelling case study |
title_short | Investigating zero transmission of HIV in the MSM population: a UK modelling case study |
title_sort | investigating zero transmission of hiv in the msm population: a uk modelling case study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659044/ https://www.ncbi.nlm.nih.gov/pubmed/37986184 http://dx.doi.org/10.1186/s13690-023-01178-0 |
work_keys_str_mv | AT masseykatherine investigatingzerotransmissionofhivinthemsmpopulationaukmodellingcasestudy AT vardanegavittoria investigatingzerotransmissionofhivinthemsmpopulationaukmodellingcasestudy AT chapondamas investigatingzerotransmissionofhivinthemsmpopulationaukmodellingcasestudy AT eddoweslucya investigatingzerotransmissionofhivinthemsmpopulationaukmodellingcasestudy AT hearmonnatalie investigatingzerotransmissionofhivinthemsmpopulationaukmodellingcasestudy |